Panacea Global Inc.

OTCBB : PANG


Panacea Global Inc.

May 28, 2014 17:45 ET

Panacea Global to Present at an Investor Conference in NYC

TORONTO, ONTARIO--(Marketwired - May 28, 2014) - Panacea Global Inc. (OTCBB:PANG), (www.panaceaglobalinc.com) ("Panacea Global" or "the Company") announced today that it will present at SeeThruEquity 3rd Annual MicroCap Investor Conference in NYC.

Location: Convene in Grand Central (101 Park Ave., New York, NY 10178)
Date: Wednesday, May 28, 2014
Time: 3:00 PM (ET)
Room: Park Hub

Panacea Global will present an overview of the Company's cancer diagnostic development and commercialization strategies.

About Panacea Global

Panacea Global is a biotechnology company focused on the development and commercialization of diagnostic products for the management of cancer. Panacea has developed an accurate, timely, cost effective and non-invasive early cancer detection test to increase the quality of life of cancer patients and ultimately saving lives. Panacea's test is based on the detection of the human aspartyl (asparaginyl) β-hydroxylase (HAAH), a novel biomarker expressed in malignant cancer cells in patients' blood samples. Panacea Global has the exclusive worldwide (excluding the USA) rights to HAAH-based cancer tests. Panacea Global Inc.'s shares are publicly traded on the OTCBB under the ticker symbol PANG in the US. More information about Panacea Global (OTCBB:PANG) is available at www.panaceaglobalinc.com.

Safe Harbor Statement

Certain information contained in this document may include forward-looking information. Without limiting the foregoing, the information and any forward-looking information may include statements regarding projects, costs, objectives and future returns of the Company or hypotheses underlying these items. In this document, words such as may, would, could, will, likely, believe, expect, anticipate, intend, plan, estimate and similar words and the negative form thereof are used to identify forward-looking statements. Forward-looking statements should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, such future performance will be achieved. Forward-looking statements and information are based on information available at the time and/or the Company management's good-faith beliefs with respect to future events and are subject to known or unknown risks, uncertainties, assumptions and other unpredictable factors, many of which are beyond the Company's control. The Company does not intend, nor does it undertake, any obligation to update or revise any forward-looking information or statements contained in this document to reflect subsequent information, events or circumstances or otherwise, except as required by applicable laws.

Contact Information